✦
UWELL CLOUD YOU JIAN YUN

West China Lecheng Hospital

EPC-cell therapy reference for severe limb ischaemia

Cell therapy using donor-derived endothelial progenitor cells for severe lower-limb ischaemia.

Historical anatomical illustration: arteries and veins · Colourized electron micrograph of a T lymphocyte
Historical anatomical illustration · Research microscopy · Image credits

Prepared by Uwell’s content team from the cited documents; not a clinician-reviewed recommendation. Source review: 10 October 2026.

Clinical details below are in English. Ask the care team for help understanding the source documents.

What to clarify

Severe limb ischaemia means markedly reduced blood supply to a limb. A proposed endothelial-progenitor-cell intervention must be distinguished from vascular assessment, wound care and established procedures to restore blood flow. The price row does not explain cell origin, delivery or emergency management.

Before your consultation

Vascular imaging; ankle or toe-pressure results; wound history; diabetes control; previous vascular procedures.

Use existing documents for the initial inquiry. The hospital should specify whether additional tests are needed after reviewing them. Arrange secure transfer of records through the care team; do not place sensitive records in a public message.

Evidence and limitations

The supplied price tables identify a named intervention and hospital, but contain no study reference, detailed safety information or patient-specific recommendation. They cannot establish current authorization, benefit, eligibility or availability. Ask for the exact product or cell preparation, the applicable clinical or research pathway and the consent information.

If offered as research, request the registry identifier, study phase, eligibility criteria, sponsor and follow-up obligations. A trial registration is a record of a study; it is not a guarantee that the intervention works.

Questions to ask

How does this relate to established vascular treatment?

A vascular specialist must assess circulation, wounds and available revascularization options. Ask why a cell approach is proposed, whether it is investigational and how usual vascular and wound care would continue.

What needs to be confirmed before I travel?

Obtain a clinical review of your documents, the exact proposed intervention, a written quotation, expected visits and a named contact for follow-up. Ask what happens if the in-person assessment changes the plan.

Price and quotation

Source reference price

CNY 100,000≈ USD 14,900Per case

West China Lecheng Hospital

Request a current quotation
Review the source

Source document undated

Original source notation: 10万/例

Approximate conversion ·
Central Bank of the UAE · exchange rates

A reference amount is not a total course price. Ask the provider to itemize assessment, testing, cell or product preparation, administration, admission, medicines and follow-up where applicable. Confirm the number of sessions, currency, quote validity and refund or cancellation terms. Accommodation, travel and Uwell coordination are separate unless the written quotation says otherwise.

Sources and editorial scope

Prepared by Uwell’s content team from the cited documents; not a clinician-reviewed recommendation. Source review: 10 October 2026.

The clinical links provide background information. They do not verify the exact hospital programme, current authorization or an individualized treatment recommendation. The original provider must supply those details.

Original catalogue entries

Source publication date: not supplied. The figures remain source references rather than a current hospital quotation.

Reference catalogue
Sariyah Ahmad
Active Triage Officer

Welcome to Uwell Cloud. Connecting from Malaysia, Indonesia, or Thailand? Ask me about visa-free travel and stem cell medical programs in Boao Lecheng.